Long-term outcomes of patients following hospitalization for coronavirus disease 2019: a prospective observational study.

Long-term outcomes of patients following hospitalization for coronavirus disease 2019: a prospective observational study.

Yolanda Meije, Alejandra Duarte-Borges, Xavier Sanz, Mercedes Clemente, Alba Ribera, Lucía Ortega, Ruth González-Pérez, Roser Cid, Júlia Pareja, Irene Cantero, Miquel Ariño, Teresa Sagués, Jaume LLaberia, Ana Ayestarán, Nuria Fernández-Hidalgo, Beatriz Candás-Estébanez

Few data are available regarding follow up of patients with coronavirus disease 2019 (COVID-19) after their discharge. We aim to describe the long-term outcomes of survivors of hospitalization for COVID-19 followed up first at an outpatient facility and subsequently by telephone. Observational prospective study conducted at a tertiary general hospital. Clinical and radiological progression was assessed and data were recorded on a standardized reporting form. Patients were divided into three groups according to Pao2/Fio2 at hospitalization: Pao2/Fio2 >300, Pao2/Fio2 300-200 and Pao2/Fio2 <200. A logistic multivariate regression model was performed to identify factors associated with persistence of symptoms. For facility follow up, 302 individuals were enrolled. Median follow up was 45 days after discharge; 78% (228/294) of patients had COVID-19-related symptoms (53% asthenia, 56% respiratory symptoms) and 40% (122/302) had residual pulmonary radiographic lesions. Pao2/Fio2 <200 was an independent predictor of persistent dyspnoea (OR 1.87, 95% CI 1.38-2.52, p < 0.0001). Pao2/Fio2 >300 was associated with resolution of chest radiographic lesions (OR 0.56, 95% CI 0.42-0.74, p < 0.0001). Fifty per cent of patients required specific medical follow up after the first consultation and were transferred to another physician. A total of 294 patients were contacted for telephone follow up after a median follow-up time of 7 months. Fifty per cent of patients (147/294) still presented symptoms and 49% (145/294) had psychological disorders. Asthenia was identified in 27% (78/294) and dyspnoea in 10% (28/294) of patients independently of Pao2/Fio2. Patients with COVID-19 require long-term follow up because of the persistence of symptoms; patients with low Pao2/Fio2 during the acute illness require special attention.

2021

Coronavirus disease 2019, follow-up, sequelae, aftermath, Outpatient facility, Pao(2)/Fio(2)

10.1016/j.cmi.2021.04.002

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases